Thyrocare Technologies Limited — Others, 23-07-2025: Change in Director(s)

Thyrocare's board approved its financial results for the quarter ended June 30, 2025, reporting consolidated revenue of 193.03 Cr and profit of 38.29 Cr. Standalone figures showed 178.89 Cr revenue and 36.05 Cr profit. Significant leadership changes include Mr. Alok Kumar Jagnani transitioning from CFO to Group CFO of API Holdings and joining Thyrocare's board as a Non-Executive Director, with Mr. Vikram Gupta appointed as the new CFO. Mr. Hardik Kishor Dedhia also resigned as a Non-Executive Director. The company further solidified its international presence by increasing its stake in Thyrocare Laboratories (Tanzania) Limited, making it a subsidiary, and infused additional capital.